Roche Backs 2025 Views After Strong Sales of Key Drugs

A stronger Swiss franc dragged relative growth reported in that currency, Roche said Roche HoldingROG2.45%increase; green up pointing triangle backed its hopes for revenue growth this year as its top line grew on higher sales of its key pharmaceutical products. The Swiss drugmaker said Thursday that …